Ginkgo Bioworks Holdings, Inc. (DNA)
Market: NYSE |
Currency: USD
Address: 27 Drydock Avenue
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
📈 Ginkgo Bioworks Holdings, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$9.00
-
Upside/Downside from Analyst Target:
4.90%
-
Broker Call:
-3
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
10-25%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.025000 |
- |
2024-08-20 |
- |
Stock split |
|
Total Amount for 2024: $0.025000 |
📅 Earnings & EPS History for Ginkgo Bioworks Holdings, Inc.
| Date | Reported EPS |
|---|
| 2025-05-06 | - |
| 2025-02-25 | -2 |
| 2024-11-12 | -0.94 |
| 2024-08-08 | -0.07 |
| 2024-08-07 | -0.07 |
| 2024-05-09 | -0.08 |
| 2024-05-08 | -0.08 |
| 2024-02-29 | -0.11 |
| 2024-02-28 | -0.11 |
| 2023-11-08 | -0.16 |
| 2023-11-07 | -0.16 |
| 2023-08-09 | -0.09 |
| 2023-08-08 | -0.09 |
| 2023-05-10 | -0.11 |
| 2023-05-09 | -0.11 |
| 2023-03-01 | -0.09 |
| 2023-02-28 | -0.09 |
| 2022-11-14 | -0.41 |
| 2022-11-13 | -0.41 |
| 2022-08-15 | -0.43 |
| 2022-08-14 | -0.43 |
| 2022-05-16 | -0.3 |
| 2022-05-15 | -0.3 |
| 2022-03-28 | -0.99 |
| 2022-03-27 | -0.99 |
| 2021-11-15 | -0.06 |
| 2021-11-14 | -0.06 |
| 2021-09-20 | - |
| 2021-09-19 | - |
📰 Related News & Research
No related articles found for "ginkgo bioworks".
